Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
ACON

ACON - Aclarion, Inc. Stock Price, Fair Value and News

$3.65+0.01 (+0.27%)
Market Closed

76/100

ACON

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

76/100

ACON

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$5.7

Target 3M

$4.22

Target 6M

$4.68

ACON Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ACON Price Action

Last 7 days

-5.2%

Last 30 days

-26.1%

Last 90 days

-52.8%

Trailing 12 Months

-98.7%

ACON RSI Chart

ACON Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ACON Valuation

Market Cap

2.5M

Price/Earnings (Trailing)

-0.33

Price/Sales (Trailing)

36.31

EV/EBITDA

1.25

Price/Free Cashflow

-0.71

ACON Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$5.7

Target 3M

$4.22

Target 6M

$4.68

ACON Fundamentals

ACON Revenue

Revenue (TTM)

67.5K

Rev. Growth (Yr)

31.48%

Rev. Growth (Qtr)

-1.95%

ACON Earnings

Earnings (TTM)

-7.3M

Earnings Growth (Yr)

-24.9%

Earnings Growth (Qtr)

-6.59%

ACON Profitability

Operating Margin

-7.83%

EBT Margin

-10867.85%

Return on Equity

-58.67%

Return on Assets

-55.56%

Free Cashflow Yield

-140.98%

ACON Investor Care

Shares Dilution (1Y)

55736.15%

Diluted EPS (TTM)

-1.2K

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202554.6K62.9K67.5K0
202460.0K53.9K49.3K45.7K
202376.9K83.3K84.1K75.4K
202257.5K42.5K49.9K60.4K
202100060.3K
Get all data in R, Python etc through our Historical Stock Data APIs

About Aclarion, Inc.

ACON
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. The company develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in Broomfield, Colorado.
 CEO
 WEBSITEaclarion.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES7

Aclarion, Inc. Frequently Asked Questions

ACON is the stock ticker symbol of Aclarion, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Aclarion, Inc. is 2.45 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check ACON's fair value in chart for subscribers.

The fair value guage provides a quick view whether ACON is over valued or under valued. Whether Aclarion, Inc. is cheap or expensive depends on the assumptions which impact Aclarion, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ACON.

As of Wed Jan 28 2026, ACON's PE ratio (Price to Earnings) is -0.33 and Price to Sales (PS) ratio is 36.31. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ACON PE ratio will change depending on the future growth rate expectations of investors.